Stay updated with breaking news from Biliary Tract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Biliary Tract Cancer - read this article along with other careers information, tips and advice on BioSpace
Investegate announcements from AstraZeneca PLC, Imfinzi improves survival in biliary tract cancer
18.01.2022 - Positive results from the TOPAZ-1 Phase III trial showed AstraZeneca’s IMFINZI (durvalumab) in combination with standard-of-care chemotherapy, demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) ...
Investegate announcements from AstraZeneca PLC, Imfinzi improved survival in biliary tract cancer
Erdafitinib (Janssen Research and Development). The anticipated launch of targeted therapies including potential FGFR gene fusions and somatic mutations in IDH 1/2 in iCCA, PRKACA or PRKACB gene fusions in pCCA, and ELF3 mutations in dCCA/ampullary carcinoma shall push the growth of the BTC market size in the offing. Further, an increase in the BTC incidence, increment in healthcare spending, extensive R&D along better awareness of cancer is expected to give the BTC market size growth a much-needed momentum. Get in touch for a holistic view of the The BTC market report also covers the ...